| NCT06050122 | Efficacy and Safety of Patidegib Gel 2% for Preventing Basal Cell Carcinomas on the Face of Adults With Gorlin Syndrome | ACTIVE_NOT_RECRUITING | PHASE3 | 2024-03-17 | 2026-08 | 2026-08 |
| NCT05675501 | Evaluation of Topical Encapsulated Benzoyl Peroxide on the Skin Microbiome and Skin Biophysical Properties | COMPLETED | PHASE1 | 2020-06-10 | 2021-07-15 | 2021-07-15 |
| NCT04308395 | Extension Study of Patidegib Topical Gel, 2% in Subjects With Gorlin Syndrome (Basal Cell Nevus Syndrome) | TERMINATED | PHASE3 | 2020-06-03 | 2021-07-14 | 2021-07-14 |
| NCT04155190 | An Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas in Patients With Non-Gorlin High Frequency BCC | TERMINATED | PHASE2 | 2019-12-20 | 2021-04-23 | 2021-04-23 |
| NCT04059523 | MUSE Study to Evaluate the Pharmacokinetics, Safety and Tolerability of S6G5T-3 | COMPLETED | PHASE1 | 2019-06-27 | 2020-02-06 | 2020-02-06 |
| NCT03703310 | Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas (BCCs) in Subjects With Basal Cell Nevus Syndrome (Gorlin Syndrome) | COMPLETED | PHASE3 | 2019-02-19 | 2020-12-28 | 2020-12-28 |
| NCT03761784 | A Study of S6G5T-3 in the Treatment of Acne Vulgaris | COMPLETED | PHASE3 | 2018-12-21 | 2019-12-31 | 2019-12-31 |
| NCT03727074 | Bioequivalence Study to Compare Sol-Gel Technologies' 5-FU Cream With Efudex® (5-FU) Cream | COMPLETED | PHASE3 | 2018-12-21 | 2019-12-19 | 2019-12-19 |
| NCT03761810 | A Study of S6G5T3 in the Treatment of Acne Vulgaris | COMPLETED | PHASE3 | 2018-12-14 | 2019-10-23 | 2019-10-23 |
| NCT03564145 | A Long-Term Safety Study of S5G4T-1 in the Treatment of Papulopustular Rosacea | TERMINATED | PHASE3 | 2018-09-12 | 2019-11-13 | 2019-11-13 |
| NCT03564119 | A Study of S5G4T-1 in the Treatment of Papularpustular Rosacea | COMPLETED | PHASE3 | 2018-06-21 | 2019-06-10 | 2019-06-10 |
| NCT03448939 | A Study of S5G4T-1 in the Treatment of Papulopustular Rosacea | COMPLETED | PHASE3 | 2018-06-18 | 2019-05-24 | 2019-05-24 |
| NCT02842021 | Efficacy and Safety of Product S2G6T-1in Patients With Symptomatic Inflammatory Interdigital Tinea Pedis | TERMINATED | PHASE2 | 2016-09 | 2017-10 | 2017-10 |
| NCT02661958 | Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris | COMPLETED | PHASE2 | 2016-05 | 2017-10 | 2017-10 |
| NCT00940992 | A Study of DER 45-EV Gel to Treat Rosacea | COMPLETED | PHASE2 | 2012-01 | 2013-01 | 2012-09 |